BiotechTube
Home/PMV Pharmaceuticals/Deepika Pakianathan, Ph.D.
DP

Deepika Pakianathan, Ph.D.

Board Member

PMV Pharmaceuticals

Therapeutic Areas

OncologyPrecision Medicine

PMV Pharmaceuticals Pipeline

DrugIndicationPhase
rezatapopt (PC14586)Advanced Solid Tumors with p53 Y220C mutationPhase 1/2
rezatapopt + azacitidineRelapsed/Refractory AML/MDS with p53 Y220C mutationInvestigator-Initiated Trial
Undisclosed ProgramSolid Tumors (other p53 hotspots)Discovery/Preclinical

Leadership Team at PMV Pharmaceuticals

DM
David Mack, Ph.D.
Co-Founder
AL
Arnold Levine, Ph.D.
Co-Founder, Professor Emeritus
TS
Thomas Shenk, Ph.D.
Co-Founder, Professor
MD
Mikael Dolsten, M.D., Ph.D.
Chairman of the Board
View full PMV Pharmaceuticals profile